Patient Guide: Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 288 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05840211
Status: ACTIVE_NOT_RECRUITING
Condition: Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 288 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Chandler, Arizona
  • Los Angeles, California
  • Palo Alto, California
  • • And 285 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily